Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/8/2026

1. IONQ
2. SPY
3. ROIV
4. AAPL
5. ACN
6. IONS
7. AZN
8. ORCL
9. HOOD
10. QCOM

Go back to Galectin Therapeutics Announces Positive Type C Meeting with the FDA for Belapectin in Patients with MASH Cirrhosis and Portal Hypertension
GALECTIN (NASDAQ: GALT) Delayed: 4.30 -0.31 (6.72%)
Previous Close $4.61    52 Week High $3.05 
Open $4.60    52 Week Low $0.49 
Day High $4.65    P/E N/A 
Day Low $4.10    EPS $-1.32 
Volume 159,341